Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and nevirapine

olmesartan has been researched along with nevirapine in 4 studies

Compound Research Comparison

Studies
(olmesartan)		Trials
(olmesartan)		Recent Studies (post-2010)
(olmesartan)		Studies
(nevirapine)		Trials
(nevirapine)		Recent Studies (post-2010) (nevirapine)
8411855543,2125091,108

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)nevirapine (IC50)
Chain B, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain B, Hiv-1 Reverse TranscriptaseHuman immunodeficiency virus 10.08
Chain A, Reverse transcriptase/ribonuclease HHuman immunodeficiency virus 11.165
Prothrombin Bos taurus (cattle)1.15
Gag-Pol polyproteinHuman immunodeficiency virus type 1 BH101.4504
Gag-Pol polyproteinHuman immunodeficiency virus type 2 (ISOLATE ROD)2.05
Gag-Pol polyproteinHIV-1 M:B_HXB2R1.4353
Imidazoleglycerol-phosphate dehydrataseSaccharomyces cerevisiae S288C1.7
Cytochrome P450 3A4Homo sapiens (human)0.181
Cytochrome P450 2C9 Homo sapiens (human)0.181
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)0.69
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.7
Microsomal triglyceride transfer protein large subunitHomo sapiens (human)5.75
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)0.18
Reverse transcriptase/RNaseH Human immunodeficiency virus 12.071
Protease Human immunodeficiency virus 10.101
Reverse transcriptase Human immunodeficiency virus 13.995

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

4 other study(ies) available for olmesartan and nevirapine

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Glutathione; Pharmacology; Sulfur Radioisotopes

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023